Trial Profile
Beta-blocker Therapy in Idiopathic Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 07 Jul 2016 Results published in the European Respiratory Journal
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
- 13 Jan 2014 Status changed from recruiting to active, no longer recruiting.